Serum osteoprotegerin levels are related to height loss: the Tromsø Study (Q34940502)

5 August 2017

Serum osteoprotegerin levels are related to height loss: the Tromsø Study (English)

1 reference

5 August 2017

6

Bjarne K Jacobsen

1 reference

5 August 2017

4

Ellisiv Mathiesen

1 reference

5 August 2017

Lone Jørgensen

1

1 reference

5 August 2017

John-Bjarne Hansen

series ordinal

2

1 reference

5 August 2017

Jan Brox

series ordinal

3

1 reference

5 August 2017

Anders Vik

series ordinal

5

1 reference

5 August 2017

18 February 2011

1 reference

European Journal of Epidemiology

5 August 2017

1 reference

5 August 2017

26

1 reference

5 August 2017

305-312

1 reference

5 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-011-9555-8

5 August 2017

0 references

cites work

Effects of height loss on morbidity and mortality in 3145 community-dwelling Chinese older women and men: a 5-year prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Update in male osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Association between height loss and bone loss, cumulative incidence of vertebral fractures and future quality of life: the Miyama study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Soluble RANKL and risk of nontraumatic fracture

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Minireview: the OPG/RANKL/RANK system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Bone resorption by osteoclasts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Longitudinal change in the heights of men and women: consequential effects on body mass index

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Height loss, forearm bone density and bone loss in menopausal women: a 15-year prospective study. The Nord-Trøndelag Health Study, Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Correlates of osteoprotegerin levels in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Serum levels of osteoprotegerin increase with age in a healthy adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Older men with low serum estradiol and high serum SHBG have an increased risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Vertebral fractures in the elderly may not always be "osteoporotic".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3088831

Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins

26 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9555-8

Contributions of vertebral fractures to stature loss among elderly Japanese-American women in Hawaii

21 January 2018

1 reference

12 December 2020

The relationship between anthropometric measurements and fractures in women

1 reference

12 December 2020

The Tromsø Study: artifacts in forearm bone densitometry--prevalence and effect

1 reference

12 December 2020

The Tromsø study: determinants of precision in bone densitometry

1 reference

12 December 2020

Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75

1 reference

12 December 2020

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

1 reference

12 December 2020

A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis

1 reference

12 December 2020

Carotid Plaque Echogenicity and Risk of Nonvertebral Fractures in Women: A Longitudinal Population-Based Study

1 reference

12 December 2020

Use of clinical risk factors to identify postmenopausal women with vertebral fractures

1 reference

12 December 2020

Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women

1 reference

12 December 2020

Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study

1 reference

12 December 2020

10.1007/S10654-011-9555-8

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference